Summary
The combination of trimethoprim (TMP) and sulfamethopyrazine (SMP) has been successfully used to treat chronic urinary tract infections. Since parenchymal involvement associated with renal insufficiency of varying degree is not infrequent in these patients, it was considered important to study the pharmacokinetics of TMP and SMP in a fixed dose combination. Four groups of patients were studied: 1) 4 patients with endogenous creatinine clearance (CLcR) between 80 and 40 ml/min; 2) 3 patients with CLcR between 40 and 10 ml/min; 3) 3 patients on chronic peritoneal dialysis (CAPD); and 4) 3 patients on haemodialysis. A single oral dose of 250 mg TMP and 200 mg SMP was given to each patient. Multiple samples were collected over 9 days and the following pharmacokinetic parameters were calculated: total area under the plasma level curve, slow disposition rate constant β and the corresponding t1/2β, plasma clearance and the apparent volume of distribution. The results show that the two moieties of the TMP-SMP combination behaved differently in uraemic patients as fas as elimination rate was concerned. TMP was eliminated more slowly both in patients with diminished renal function and in those subjected to haemo- or peritoneal dialysis. The reduction in the rate of elimination of TMP was significantly correlated with the degree of renal impairment. The elimination of SMP, however, was not significantly affected by the reduced renal function; indeed a tendency to increase was noted, at least in dialyzed patients. However, as in patients with mild renal insufficiency (CLcR>40 ml/min) no substantial change in plasma clearance rate need be expected, the TMP-SMP combination could be given to them in the same dose schedule as in people with normal renal function.
Similar content being viewed by others
References
Baethke R, Golde G, Gahl G (1972) Sulphamethoxazole/trimethoprim: pharmacokinetic studies in patients with chronic renal failure. Eur J Clin Pharmacol 4: 233–240
Bushby SRM (1975) Synergy of trimethoprim-sulfamethoxazole. Can Med Assoc J 112: 63–66
Bushby SRM, Hitchings GH (1968) Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother 33: 72–90
Bratton A, Marshall SK (1983) A new coupling component for sulfanilamide determination. J Biol Chem 128: 537–550
Devriendt A, Jansen FH, Weemaes I (1970) Pharmacokinetics of sulfametopyrazine (Kelfizine W). Effects of a single oral dose. Eur J Clin Pharmacol 3: 36–42
Kaplan S, Weinfeld RE, Abruzzo CW, McFaden K, Lewis Jack M, Weissman L (1974) Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. In: Finland M, Hass EH (ed) Trimethoprim-sulfamethoxazole. University of Chicago Press, Chicago, pp 115–125
Lott RS, Hayton WL (1978) Estimation of creatinine clearance from serum creatinine concentration. Drug Intell Clin Pharmacol 12: 140–150
Marchioni CF, Corradini M, Carra R, Pellegrino M, Guerzoni P, Morandi V, Bianchi A, Piaia F (1983) Distribution of the combination trimethoprim-sulfamethopyrazine in the ratio 5: 4 in the human respiratory tract. Chemioterapia 2: 343–348
Morgan DJ, Raymond K (1980) Evaluation of slow infusions of cotrimoxazole by using predictive pharmacokinetics. Antimicrob Agents Chemother 17: 132–137
Pavone-Macaluso M, Di Trapani D, Rizzo F, Ascoli R, Corrado F, Maver A, Piaia F (1981) Kelfiprim, a combination of sulfamethopyrazine and trimethoprim in chronic prostatitis. Pharmacokinetics and preliminary clinical results. In: Periti P, Grassi GG (eds) Current chemotherapy and immunotherapy (Proc 12th Int Congr Chemother, Florence) The American Society for Microbiology, Washington, Vol. 1, pp 244–245
Reeves DS, Bywater MJ, Bullock DW, Holt HA (1980) Pharmacokinetic study of a sulfamethopyrazine-trimethoprim combination (Kelfiprim) in human volunteers. J Antimicrob Chemother 6: 647–656
Rieder J (1972) Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy 17: 1–21
Sardi A, Vettaro MP, Alesina R, Grasso S, Meinardi G, De Carneri I, Tamassia V (1981) Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man. Eur J Clin Pharmacol 20: 113–118
Schioppacassi G, Mandelli V, Mazzoleni R, Morvillo E (1979) Studio dell'interazione sulfametossipirazina-trimethoprim su schizomiceti in vitro. Giorn It Chemioter 26: 181–188
Sharpstone P (1969) The renal handling of trimethoprim and sulfamethoxazole in man. Postgrad Med J 45: 38–42
Welling PG, Craig WA, Amidon GL, Kunin CM (1974) Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure. In: Finland M, Hass EH (eds) Trimethoprim-sulfamethoxazole. University of Chicago Press, Chicago pp 124–134
Wormser GP (1978) Trimethoprim-Sulfamethoxazole. NY State J Med 78: 1915–1921
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cantaluppi, A., Graziani, G., Ponticelli, C. et al. Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency. Eur J Clin Pharmacol 27, 345–348 (1984). https://doi.org/10.1007/BF00542173
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542173